Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical specificity profile for novel rapid acting antidepressant drugs
Mauro Scala, Giuseppe Fanelli, Diana De Ronchi, et al.
International Clinical Psychopharmacology (2023) Vol. 38, Iss. 5, pp. 297-328
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Chinese herbal medicines for the treatment of depression: a systematic review and network meta-analysis
Chun Dang, Qinxuan Wang, Qian Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 28
Dextromethorphan/Bupropion: A Novel Treatment for Patients With Major Depressive Disorder
Kristine C. Willett, LeDea R. Bond, Amanda M. Morrill, et al.
American Journal of Therapeutics (2024) Vol. 31, Iss. 1, pp. e24-e29
Closed Access | Times Cited: 6
Xenon gas as a potential treatment for opioid use disorder, alcohol use disorder, and related disorders
Marc J. Kaufman, Edward G. Meloni
Medical Gas Research (2025)
Closed Access
Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sex
Maria Antonietta De Luca, Antonina Luca, A. Messina, et al.
Journal of Affective Disorders (2025)
Closed Access
Unlocking the Link Between Gut Microbiota and Psychopathological Insights in Anorexia Nervosa: A Systematic Review
Mauro Scala, Mariangela Tabone, Marco Paolini, et al.
European Eating Disorders Review (2025)
Open Access
Anhedonia: Current and future treatments
Alessandro Serretti
Psychiatry and Clinical Neurosciences Reports (2025) Vol. 4, Iss. 1
Open Access
Antidepressant treatment in complex clinical pictures
Alessandro Serretti
International Clinical Psychopharmacology (2025) Vol. 40, Iss. 3, pp. 123-126
Closed Access
Astrocytic GABAergic Regulation in Alcohol Use and Major Depressive Disorders
Dina Ali, H. Mokdad Ali, Matthew R. Lopez, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 318-318
Open Access | Times Cited: 4
The emergence of antidepressant drugs targeting GABAA receptors: A concise review
Xénia Gonda, Frank I. Tarazi, Péter Döme
Biochemical Pharmacology (2024) Vol. 228, pp. 116481-116481
Open Access | Times Cited: 4
The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression
Maria Pepe, Giovanni Bartolucci, Ilaria Marcelli, et al.
Brain Sciences (2023) Vol. 13, Iss. 10, pp. 1494-1494
Open Access | Times Cited: 10
Pediatric suicide: Review of a preventable tragedy
Donald E. Greydanus, Ahsan Nazeer, Zheala Qayyum, et al.
Disease-a-Month (2024) Vol. 70, Iss. 9, pp. 101725-101725
Closed Access | Times Cited: 3
A Critical View on New and Future Antidepressants
Alessandro Serretti
Clinical Psychopharmacology and Neuroscience (2024) Vol. 22, Iss. 2, pp. 201-210
Open Access | Times Cited: 2
Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis
Abdullah Ahmad, Abdul Rafeh Awan, Natasha Nadeem, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD)
Berend Olivier, Berend Olivier
Advances in experimental medicine and biology (2024), pp. 49-66
Closed Access | Times Cited: 2
Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues
Paolo Olgiati, Siegfried Kasper, Joseph Zohar, et al.
Journal of Affective Disorders (2024)
Closed Access | Times Cited: 2
Is Pilates effective in improving depressive disorders? A comprehensive overview
F Legnani, Lorenzo Tassi, Teresa Surace, et al.
International Clinical Psychopharmacology (2024) Vol. 40, Iss. 2, pp. 53-61
Open Access | Times Cited: 1
Understanding and treating postpartum depression: a narrative review
Vincenzo Cardaci, Matteo Carminati, Mattia Tondello, et al.
International Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 1
Cognitive Dysfunction in Unipolar Depression
C. Rakesh, Rachit Sharma, Charanpreet Singh
Indian Journal of Psychological Medicine (2024)
Open Access | Times Cited: 1
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges
Mauro Scala, Chiara Fabbri, Paolo Fusar‐Poli, et al.
CNS Spectrums (2024), pp. 1-15
Closed Access | Times Cited: 1
The pharmacological management of treatment-resistant depression: what does the future hold?
Alessandro Serretti
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 18, pp. 1923-1925
Open Access | Times Cited: 3
On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.
Daniël Hoyer
Authorea (Authorea) (2024)
Open Access
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive disorders
Д. В. Куркин, Е. И. Морковин, Д. А. Бакулин, et al.
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 5, pp. 22-22
Closed Access
The role of psilocybin in depressive disorders
Jadwiga Najib
Current Medical Research and Opinion (2024) Vol. 40, Iss. 10, pp. 1793-1808
Closed Access
Anhedonia is associated with a specific depression profile and poor antidepressant response
Antonina Luca, Maria Antonietta De Luca, Siegfried Kasper, et al.
The International Journal of Neuropsychopharmacology (2024) Vol. 27, Iss. 12
Open Access
Pherines in Psychiatry: A Potential New Paradigm for the Treatment of Mental Disorders
Thea Anderson, Catriona B. Hong
American Journal of Psychiatry Residents Journal (2024) Vol. 20, Iss. 2, pp. 22-24
Open Access
Page 1 - Next Page

Scroll to top